89bio Historical Income Statement
| ETNB Stock | USD 9.64 0.91 10.42% |
Historical analysis of 89bio income statement accounts such as Interest Expense of 4.9 M or Selling General Administrative of 35 M can show how well 89bio Inc performed in making a profits. Evaluating 89bio income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of 89bio's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining 89bio Inc latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether 89bio Inc is a good buy for the upcoming year.
89bio |
About 89bio Income Statement Analysis
89bio Inc Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to 89bio shareholders. The income statement also shows 89bio investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
89bio Income Statement Chart
Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of 89bio Inc. It is also known as 89bio overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from 89bio's income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into 89bio Inc current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. At present, 89bio's Depreciation And Amortization is projected to increase significantly based on the last few years of reporting. The current year's Interest Expense is expected to grow to about 4.9 M, whereas Tax Provision is forecasted to decline to 10,000.
| 2022 | 2023 | 2024 | 2025 (projected) | Reconciled Depreciation | 65K | 49K | 56.4K | 50.6K | Total Operating Expenses | 102.2M | 151.2M | 173.9M | 182.6M |
89bio income statement Correlations
Click cells to compare fundamentals
89bio Account Relationship Matchups
High Positive Relationship
High Negative Relationship
89bio income statement Accounts
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 (projected) | ||
| Tax Provision | (59K) | (147K) | 19K | 16K | 14.4K | 10K | |
| Depreciation And Amortization | 60K | 79K | 240K | 273K | 314.0K | 329.6K | |
| Interest Expense | 143K | 447K | 1.9M | 3.6M | 3.2M | 4.9M | |
| Selling General Administrative | 13.2M | 19.4M | 21.5M | 29.0M | 33.3M | 35.0M | |
| Other Operating Expenses | 49.4M | 89.7M | 102.2M | 151.2M | 173.9M | 182.6M | |
| Operating Income | (49.4M) | (89.7M) | 102.2M | (151.2M) | (136.1M) | (129.3M) | |
| Net Income From Continuing Ops | (49.5M) | (90.1M) | (102.0M) | (126.6M) | (113.9M) | (119.6M) | |
| Ebit | (49.4M) | (89.7M) | (100.1M) | (134.7M) | (121.3M) | (115.2M) | |
| Research Development | 36.2M | 70.3M | 80.8M | 122.2M | 140.6M | 147.6M | |
| Ebitda | (49.3M) | (89.7M) | (99.8M) | (134.5M) | (121.0M) | (115.0M) | |
| Total Operating Expenses | 49.4M | 89.7M | 102.2M | 151.2M | 173.9M | 182.6M | |
| Reconciled Depreciation | 60K | 79K | 65K | 49K | 56.4K | 50.6K | |
| Income Before Tax | (49.6M) | (90.3M) | (102.0M) | (138.3M) | (124.5M) | (118.3M) | |
| Total Other Income Expense Net | (203K) | (526K) | 242K | 12.9M | 14.8M | 15.6M | |
| Net Income Applicable To Common Shares | (57.4M) | (49.5M) | (90.1M) | (102.0M) | (91.8M) | (96.4M) | |
| Net Income | (49.5M) | (90.1M) | (102.0M) | (142.2M) | (128.0M) | (121.6M) | |
| Income Tax Expense | (59K) | (147K) | 19K | 3.9M | 4.4M | 4.7M | |
| Gross Profit | (60K) | (79K) | (240K) | (273K) | (245.7K) | (233.4K) | |
| Cost Of Revenue | 60K | 79K | 240K | 273K | 314.0K | 329.6K |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether 89bio Inc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of 89bio's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of 89bio Inc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on 89bio Inc Stock:Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in 89bio Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors. You can also try the Instant Ratings module to determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of 89bio. If investors know 89bio will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about 89bio listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
The market value of 89bio Inc is measured differently than its book value, which is the value of 89bio that is recorded on the company's balance sheet. Investors also form their own opinion of 89bio's value that differs from its market value or its book value, called intrinsic value, which is 89bio's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because 89bio's market value can be influenced by many factors that don't directly affect 89bio's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between 89bio's value and its price as these two are different measures arrived at by different means. Investors typically determine if 89bio is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, 89bio's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.